4.625
Nephros Inc stock is traded at $4.625, with a volume of 10,370.
It is down -1.39% in the last 24 hours and up +30.28% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$4.69
Open:
$4.7
24h Volume:
10,370
Relative Volume:
0.57
Market Cap:
$50.23M
Revenue:
$19.12M
Net Income/Loss:
$776.00K
P/E Ratio:
65.51
EPS:
0.0706
Net Cash Flow:
$-348.00K
1W Performance:
+9.86%
1M Performance:
+30.28%
6M Performance:
+12.80%
1Y Performance:
+15.62%
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
1.86 | 2.83B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.89 | 388.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.88 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
5.45 | 348.74M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
48.03 | 0 | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros (NEPH) director Arthur Amron granted 2,418 shares, holds 140,874 - Stock Titan
August 2026's Promising Penny Stocks - simplywall.st
Nephros (NEPH) Q2 2026 Earnings Call Transcript - AOL.com
NEPHROS INC Q2 2026: Revenue $6.02M, Net income $1.2M, EPS $0.11— 10-Q Summary - TradingView
Nephros (NEPH) boosts Q2 2026 profit on revenue growth and tariff refund - Stock Titan
Nephros, Inc. (NPJP.F) stock price, news, quote and history - Yahoo Finance UK
Nephros Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nephros, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Is Nephros Inc (NEPH) Overvalued After Q2 Earnings Beat? EPS at - GuruFocus
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ... By GuruFocus - Investing.com Canada
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Re - GuruFocus
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ... - Yahoo Finance UK
NEPH: Record revenue and net income driven by broad-based growth and operational execution - TradingView
Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket - Investing.com
Nephros Q2 2026 Earnings: Revenue Rises 36% as Tariff Refund Lifts Margins - TradingKey
Q2 2026 Nephros Inc Earnings Call Transcript - GuruFocus
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 - marketscreener.com
Press Release: Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 - Moomoo
NEPH: Record revenue and net income growth in Q2 2026, driven by recurring and service revenues - TradingView
Nephros posts record Q2 revenue $6.0M, net income $1.2M; Adjusted EBITDA $1.3M - TradingView
Nephros, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nephros says its service offerings nearly tripled during Q2 - Stock Titan
Nephros Schedules Second Quarter 2026 Financial Results Conference Call - The Manila Times
Nephros to File Q2 Results After Close, Host 4:30 ET Call - Stock Titan
Nephros to report Q2 2026 financial results and host earnings call on August 6 - Pluang
Nephros, Inc. Revenue Breakdown – NASDAQ:NEPH - TradingView
Nephros Inc (NEPH) Institutional Confidence - TradingKey
Nephros Inc (NEPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NEPH|Nephros Inc|Price:3.450|Chg%:-0.190 - TradingKey
NEPH|Nephros Inc|Price:3.640|Chg%:-0.130 - TradingKey
Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nephros Inc. (NEPH) Retreats 3.45% as Stock Tests Key Support ZoneATR Trailing Stop - po-news-eg.net
Nephros Inc (NEPH) Cash Flow - TradingKey
Nephros Inc (NEPH) Balance Sheet - TradingKey
Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Nephros (NEPH) Edges Higher Amid Support Test: Can It Challenge Resistance?Exhaustion Gap - dars.gov.et
Nephros to Present at Maxim Group’s “Health, Wellness & Longevity” Virtual Summit on July 22, 2026 - Quiver Quantitative
Nephros to Participate in the 'Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET - The Manila Times
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET - GlobeNewswire Inc.
Nephros added to Russell Microcap Index - MSN
Northland Securities Initiates Coverage on Nephros With Market Perform Rating, $4 Price Target - Moomoo
Nephros | 8-K: Current report - Moomoo
Northland initiates Nephros stock coverage with $4 price target By Investing.com - Investing.com South Africa
Northland Securities Initiates Nephros(NEPH.US) With Hold Rating, Announces Target Price $4 - Moomoo
Northland initiates Nephros stock coverage with $4 price target - Investing.com
Nephros Inc. (NEPH) Q1 2026 Earnings: EPS Misses Estimate by Narrow Margin, Stock DeclinesProfit Recovery Report - dars.gov.et
Nephros Inc. (NEPH) Gains 3.7% as Shares Test Key Resistance Near $3.81Keltner Channel - dars.gov.et
Price to sales forward of Nephros, Inc. – NASDAQ:NEPH - TradingView
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):